Mergers & Acquisitions - Biotechnology, GlaxoSmithKline

Filter

Popular Filters

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos

30-05-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

M&A briefs: GlaxoSmithKline/Response Genetics; Bayer/Teva unit

16-09-2012

USA-based Response Genetics (Nasdaq: RGDX) last week entered into a purchase agreement with UK pharma…

BayerBiotechnologyFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResponse GeneticsTeva Pharmaceutical Industries

US FDA clears Amarin's Vascepa, a competitor for Lovaza

30-07-2012

The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

Human Genome capitulates, accepting raised offer from GlaxoSmithKline

17-07-2012

Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline $2.6 billion tender offer for Human Genome Sciences saga continues

02-07-2012

Continuing its attempts to gain control of its development partner Human Genome Sciences (Nasdaq: HGSI),…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Zacks analysts view progress of GSK bid for Human Genome Sciences

05-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Human Genome adopts Rights Plan to thwart GSK hostile takeover

18-05-2012

US biotech company Human Genome Sciences (Nasdaq: HGSI) said yesterday that, after carefully reviewing…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline buys full control of Cellzome

16-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately held Cambridge…

BiotechnologyCellzomeGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Human Genome rejects unsolicited takeover bid from GlaxoSmithKline

20-04-2012

US drugmaker Human Genome Sciences (Nasdaq: HGSI) revealed yesterday that it has rejected an unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline may be ready to acquire Human Genome, newspaper reports

18-10-2011

Shares of the UK’s biggest pharmaceuticals group, GlaxoSmithKline (LSE: GSK) amid revived speculation…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline gets 25% stake in spin-out firm Autifony

23-08-2011

UK pharma giant GlaxoSmithKline (LSE: GSK) has invested £1.25 million ($2.1 million) to receive a…

Autifony TherapeuticsBiotechnologyFinancialGlaxoSmithKlineMergers & Acquisitions

Back to top